XML 49 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity
12 Months Ended
Dec. 31, 2015
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
STOCKHOLDERS’ EQUITY
 
Authorized shares of common stock

At our annual meeting of stockholders held on July 22, 2015, the stockholders approved an amendment to the Certificate of Incorporation, as described in our proxy statement dated June 18, 2015, to increase the authorized shares of common stock from 15,000,000 to 30,000,000.

Common stock follow-on offering

On September 11, 2015, we announced the pricing of a registered underwritten follow-on offering of shares of our common stock by us and certain of our stockholders (the "Selling Stockholders"). We sold 1,500,000 shares of our common stock at a purchase price to the public of $17.00 per share and the Selling Stockholders sold an additional 1,500,000 shares of our common stock on the same terms and conditions.

The offering closed on September 16, 2015 and we received $23.6 million in net proceeds from the transaction, after giving effect to underwriting discounts and commissions and estimated expenses. We expect to use the net proceeds from the offering to finance our growth efforts, for working capital, and other general corporate purposes.

Public offering
 
On August 6, 2014, we announced the pricing of a public offering to sell 1,175,000 shares of our common stock at a price of $4.50 per share to the public. The underwriters for the offering were given an option to purchase up to an additional 176,250 shares at $4.50 per share to cover over allotments. On August 8, 2014, they exercised their option to purchase the 176,250 additional shares. The offering closed on August 11, 2014. The net proceeds we received from the offering, after deducting the underwriting discount and offering expenses paid by us, were $5.15 million, including the underwriter’s exercise of the overallotment.
 
As part of the underwriting agreement, we issued a warrant for 47,000 shares to the underwriter representing four percent of the number of shares of common stock sold in the offering at an issue price of $5.40 per share representing 120 percent of the public offering price of the shares of common stock. In conjunction with the registered offering, our common stock began trading on The NASDAQ Capital Market (“NASDAQ”) under the symbol EFOI on August 7, 2014. The warrant was exercised on September 10, 2015.
 
Convertible debt
 
Between the fourth quarter of 2012 and October of 2013, we entered into unsecured convertible notes totaling $7.6 million. The notes were convertible into shares of our common stock at $2.30 per share at various dates beginning on April 2013 through February 2014. As of March 31, 2014, all of the convertible debt had been converted into 3,323,913 shares of our common stock.
 
Warrants

We have issued warrants in conjunction with various equity issuances, debt financing arrangements, and sales incentives. Additionally, there was a warrant issued to a former employee in 2013 as part of the sales of our pool products business, which was exercised in May 2015.
 
A summary of warrant activity was as follows:
 
 
Warrants
Outstanding
 
Weighted
Average
Exercise Price
During Period
 
 
 
 
Balance, December 31, 2012
1,305,638

 
$
7.60

Warrants issued
2,549

 
3.49

Warrants expired
(200,638
)
 
19.70

Balance, December 31, 2013
1,107,549

 
4.41

Warrants issued
147,000

 
4.65

Warrants expired
(285,000
)
 
3.87

Balance, December 31, 2014
969,549

 
4.61

Warrants exercised
(638,189
)
 
4.58

Warrants cancelled/forfeited
(112,110
)
 
5.54

Warrants expired
(205,000
)
 
4.20

Balance, December 31, 2015
14,250

 
$
4.30

 
 
 
 
Exercisable, December 31, 2015

 
$



The number of warrants and weighted average remaining life (in years) by price for outstanding and exercisable warrants at December 31, 2015 was as follows:
WARRANTS OUTSTANDING
 
WARRANTS EXERCISABLE
Exercise
Price
 
Number of
Shares
Outstanding
 
Weighted
Average
Remaining
Contractual
Life
 
Number of
Shares
Exercisable
 
Weighted
Average
Exercise Price
 
 
 
 
 
 
 
 
 
$
4.30

 
14,250

 
2.07 years
 

 
$


 
Stock-based compensation
 
On May 6, 2014, our Board of Directors approved the Energy Focus, Inc. 2014 Stock Incentive Plan (the “2014 Plan”). The 2014 Plan was approved by the stockholders at our annual meeting on July 15, 2014, after which no further awards could be issued under the Energy Focus, Inc. 2008 Incentive Stock Plan (the “2008 Plan”). The 2014 Plan allows for awards up to 600,000 shares of common stock and expires on July 15, 2024. On July 22, 2015, the stockholders approved an amendment to the 2014 Plan to increase the shares available for issuance under the 2014 Plan by an additional 600,000 shares. We have two other equity-based compensation plans under which options are currently outstanding; however, no new awards may be granted under these plans. Generally, stock options are granted at fair market value and expire ten years from the grant date. Employee grants generally vest in three or four years, while grants to non-employee directors generally vest in one year. The specific terms of each grant are determined by our Board of Directors. At December 31, 2015, 795,169 shares remain available to grant under the 2014 Plan.
 
In November 2013, as a result of the sale of the pool products business, our Board of Directors approved the acceleration of the vesting of 7,000 options with a grant price of $2.30 per share for those employees who were being terminated as part of the sale. Additionally, the period in which these grants could be exercised was extended from three months from the date of termination to one year.
 
We granted 5,122 restricted stock units during the third quarter of 2013; however, 1,463 were forfeited in 2013 and 2,439 were forfeited in 2014. The remaining 1,220 shares vested in July of 2014. The fair market value on the date of grant was $4.10 per share, and the shares vested one year from the grant date.
 
Stock-based compensation expense is attributed to the granting of stock options, restricted stock, and restricted stock unit awards. For all stock-based awards, we recognize compensation expense using a straight-line amortization method.
 
The impact on our results for stock-based compensation was as follows (in thousands):
 
 
For the year ended December 31,
 
2015
 
2014
 
2013
 
 
 
 
 
 
Cost of sales
$
38

 
$
14

 
$
5

Product development
37

 
8

 
28

Selling, general, and administrative
738

 
510

 
168

Total stock-based compensation
$
813

 
$
532

 
$
201


 
At December 31, 2015 and 2014, we had unearned stock compensation expense of $992 thousand and $387 thousand, respectively. These costs will be charged to expense and amortized on a straight-line basis in subsequent periods. The remaining weighted average period over which the unearned compensation is expected to be amortized was approximately 1.9 and 2.6 years as of December 31, 2015 and 2014, respectively.
 
Stock options
 
The fair value of each stock option is estimated on the date of grant using the Black-Scholes option pricing model. Estimates utilized in the calculation include the expected life of the option, risk-free interest rate, and expected volatility, and are further comparatively detailed as follows:
  
 
2015
 
2014
 
2013
 
 
 
 
 
 
Fair value of options issued
$
5.33

 
$
3.62

 
$
2.15

Exercise price
$
7.23

 
$
4.69

 
$
2.99

Expected life of option (in years)
5.8

 
5.7

 
7

Risk-free interest rate
1.7
%
 
1.8
%
 
1.4
%
Expected volatility
90.7
%
 
97.9
%
 
92.0
%
Dividend yield
0.00
%
 
0.00
%
 
0.00
%

 
 
The estimated expected life of the option is calculated based on contractual life of the option, the vesting life of the option, and historical exercise patterns of vested options. The risk-free interest rate is based on U.S. treasury zero-coupon yield curve on the grant date for a maturity similar to the expected life of the option. The volatility estimates are calculated using historical volatility of our stock price calculated over a period of time representative of the expected life of the option. We have not paid dividends in the past, and do not expect to pay dividends over the corresponding expected term as of the grant date.

Options outstanding under all plans at December 31, 2015 have a contractual life of ten years, and vesting periods between one and four years. A summary of option activity under all plans was as follows:
 
Number of
Options
 
Weighted
Average
Exercise Price
Per Share
 
 
 
 
Outstanding at December 31, 2012
218,458

 
$
22.00

Granted
207,950

 
3.15

Cancelled
(138,220
)
 
7.74

Exercised
(2,000
)
 
5.15

Outstanding at December 31, 2013
286,188

 
15.30

Granted
326,250

 
4.76

Cancelled
(145,873
)
 
12.38

Exercised
(7,294
)
 
2.30

Outstanding at December 31, 2014
459,271

 
8.95

Granted
340,500

 
8.65

Cancelled
(147,152
)
 
10.10

Exercised
(50,412
)
 
4.69

Outstanding at December 31, 2015
602,207

 
$
8.58

 
 
 
 
Vested and expected to vest at December 31, 2015
565,137

 
$
8.71

 
 
 
 
Exercisable at December 31, 2015
304,610

 
$
9.38


 
The “Expected to Vest” options are the unvested options that remain after applying the pre-vesting forfeiture rate assumption to total unvested options. The total intrinsic value of options exercised during 2015 was $485 thousand. The total intrinsic value of options outstanding and options exercisable at December 31, 2015 was $4.2 million and $2.3 million, respectively, which was calculated using the closing stock price at the end of the year of $13.75 per share less the option price of the in-the-money grants.
 
The options outstanding at December 31, 2015 have been segregated into ranges for additional disclosure as follows:
 
OPTIONS OUTSTANDING
 
OPTIONS EXERCISABLE
Range of Exercise Prices
 
Number of Shares Outstanding
 
Weighted Average Remaining Contractual Life (in years)
 
Weighted Average Exercise Price
 
Number of Shares Exercisable
 
Weighted Average Remaining Contractual Life (in years)
 
Weighted Average Exercise Price
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$2.30
$4.00
 
61,218

 
7.3
 
$
2.33

 
60,586

 
7.3
 
$
2.33

$4.01
$4.45
 
132,778

 
8.1
 
4.10

 
114,187

 
8.1
 
4.10

$4.46
$5.48
 
198,200

 
9.1
 
5.42

 
25,700

 
8.5
 
5.07

$5.49
$13.58
 
108,011

 
7.5
 
8.36

 
62,137

 
6.8
 
8.46

$13.59
$71.90
 
102,000

 
7.4
 
24.56

 
42,000

 
4.0
 
37.89

 
 
 
 
602,207

 
8.1
 
$
8.58

 
304,610

 
7.1
 
$
9.38



Restricted stock and Restricted Stock Units
 
Prior to 2011, we issued restricted stock to Executive Officers and Directors in lieu of paying a portion of their cash compensation or Directors’ fees. Beginning in 2015, we began issuing restricted stock units to employees and certain non-employee Directors under the 2014 Plan.
 
The following table shows a summary of restricted stock and restricted stock unit activity:
 
 
Restricted
Stock
Outstanding
 
Restricted Stock Units Outstanding
 
Weighted
Average
Grant Date
Fair Value
 
 
 
 
 
 
At December 31, 2012
41,461

 

 
$
7.31

Granted

 

 

Vested
(5,592
)
 

 
7.31

At December 31, 2013
35,869

 

 
7.31

Granted

 

 

Vested
(35,869
)
 

 
7.31

At December 31, 2014

 

 

Granted

 
73,750

 
6.92

Cancelled

 
(16,250
)
 
5.54

At December 31, 2015

 
57,500

 
$
7.31


  
Employee stock purchase plans
 
In September 2013, our stockholders approved the 2013 Employee Stock Purchase Plan (the “2013 Plan”) to replace the 1994 prior purchase plan. A total of 500,000 shares of common stock were provided for issuance under the 2013 Plan. The 2013 Plan permits eligible employees to purchase common stock through payroll deductions at a price equal to the lower of 85 percent of the fair market value of our common stock at the beginning or end of the offering period. Employees may end their participation at any time during the offering period, and participation ends automatically upon termination of employment with us. During 2015, 2014 and 2013, employees purchased 18,119, 9,932, and 17,655 shares, respectively. At December 31, 2015, 465,535 shares remained available for purchase under the 2014 Plan.